Salinosporamide Biosynthesis and Engineering
盐孢酰胺生物合成与工程
基本信息
- 批准号:7251108
- 负责人:
- 金额:$ 28.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:Acetyl Coenzyme AAmino AcidsAnabolismAntineoplastic AgentsApplications GrantsBacteriaBindingBiochemical GeneticsBiologicalBiological AssayButyratesCancer BiologyCell NucleusChemical StructureChemicalsClinicalClinical TrialsCoenzyme ADataDevelopmentDrug Delivery SystemsEngineeringEnzymesEvaluationFermentationFoundationsFutureGene ClusterGenerationsGenesGeneticGenomeHomologous GeneHumanHybridsLactamsLactonesLigaseMalonyl Coenzyme AMarinesMetabolicMetabolismMethionineMiningModelingMultiple MyelomaMutagenesisNumbersPathway interactionsPharmaceutical PreparationsPhaseProcessProteasome InhibitionProtein BiochemistryRecombinantsReportingResearch PersonnelResistanceShunt DeviceSolidVariantanalogbacterial resistancebasebeta-Lactamsbutyratechemical synthesiscytotoxicitydesignenzyme biosynthesishalogenationinterdisciplinary approachmarine natural productmulticatalytic endopeptidase complexmutantnovelpeptide synthasepharmacophorepolyketide synthaseprogramsprotein expressionsalinosporamide Astructural biology
项目摘要
DESCRIPTION (provided by applicant): Salinosporamide A is a potent anticancer agent that entered phase 1 human clinical trials in May 2006 for the treatment of multiple myeloma only three years after its discovery from the obligate marine bacterium Salinispora tropica. This novel marine natural product possesses a densely functionalized gamma-lactam-beta-lactone pharmacophore that is responsible for its irreversible binding to the 20S proteasome, a new drug target validated in cancer biology. Despite its clinical promise and its novel chemical structure, there are no reports on how this fermented drug is naturally created. The elucidation of the biosynthetic pathway to the salinosporamides will provide a number of opportunities to impact how salinosporamide A is commercially produced in the long-term and to afford ready access to new fermentation-based chemical variants for SAR studies through rational metabolic engineering. In addition, its unique chemical structure provides a number of rare opportunities to discover new biosynthetic processes that may have applied value as biocatalysts. Building upon a solid preliminary data foundation in which we have sequenced the 5.2 Mbp genome of S. tropica and identified the salinosporamide biosynthetic gene cluster through genome mining, mutagenesis, and protein expression, we propose in this new grant application to 1) elucidate the biosynthesis of the two novel biosynthetic building blocks chloroethylmalonyl-CoA and beta-hydroxycyclohexenylalanine, 2) characterize the salinosporamide synthetase, an unprecedented hybrid polyketide synthase-peptide synthetase for gamma-lactam-beta-lactone assembly, 3) genetically engineer and biologically evaluate new salinosporamide analogs, and 4) characterize the salinosporamide resistant 20S proteasome p-unit as a model for proteasome resistance for the future development of second-generation drugs.
描述(申请人提供):盐孢酰胺A是一种有效的抗癌药物,在从热带盐孢杆菌专属海洋细菌中发现仅三年后,于2006年5月进入第一阶段人类临床试验,用于治疗多发性骨髓瘤。这种新型海洋天然产物具有密集功能化的伽马-内酰胺-β-内酯药效团,负责其与20S蛋白酶体的不可逆结合,20S蛋白酶体是癌症生物学中验证的新药靶点。尽管它的临床前景和它新颖的化学结构,但还没有关于这种发酵药物是如何自然产生的报道。盐孢子酰胺生物合成途径的阐明将为影响盐孢子胺A的长期商业生产提供大量机会,并为通过合理的代谢工程进行SAR研究提供新的基于发酵的化学变体。此外,其独特的化学结构为发现新的生物合成过程提供了许多难得的机会,这些过程可能作为生物催化剂具有应用价值。在坚实的初步数据基础上,我们已经对热带葡萄球菌5.2Mbp的基因组进行了测序,并通过基因组挖掘、突变和蛋白质表达鉴定了盐孢酰胺生物合成基因簇,在这项新的拨款申请中,我们建议1)阐明两个新的生物合成构件氯乙基丙二酰辅酶A和β-羟基环己基丙氨酸的生物合成,2)表征盐孢酰胺合成酶,这是一种前所未有的用于伽马-内酰胺-β-内酯组装的混合型聚酮合成酶-肽合成酶,3)对新的盐孢子胺类似物进行基因工程和生物评价,以及4)表征耐盐孢子胺的20S蛋白体蛋白酶体单位,作为未来第二代药物开发的蛋白质组耐药模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRADLEY S MOORE其他文献
BRADLEY S MOORE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRADLEY S MOORE', 18)}}的其他基金
Biosynthesis and Monitoring of the Cyanobacterial Toxin Anatoxin-a(s)
蓝藻毒素 Anatoxin-a(s) 的生物合成和监测
- 批准号:
10042382 - 财政年份:2020
- 资助金额:
$ 28.14万 - 项目类别:
Biosynthesis and Monitoring of the Cyanobacterial Toxin Anatoxin-a(s)
蓝藻毒素 Anatoxin-a(s) 的生物合成和监测
- 批准号:
10237216 - 财政年份:2020
- 资助金额:
$ 28.14万 - 项目类别:
Targeted discovery of antibiotics from cave bacteria
从洞穴细菌中有针对性地发现抗生素
- 批准号:
9107281 - 财政年份:2016
- 资助金额:
$ 28.14万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 28.14万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 28.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 28.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 28.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 28.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 28.14万 - 项目类别:
Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 28.14万 - 项目类别:
Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 28.14万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 28.14万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 28.14万 - 项目类别: